我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的隐私政策。
相关临床试验
488
36 进行中
药物批准
0
批准总数
监管机构
监管机构数
成立时间
N/A
进行中(未招募)
17
3.5%
已完成
279
57.2%
Enrolling By Invitation
4
0.8%
尚未招募
15
3.1%
招募中
42
8.6%
终止
69
14.1%
Unknown
6
1.2%
撤回
56
11.5%
暂无批准数据
- A Penn State-led team developed STREAM, a platform that rapidly grows and analyzes bacteria to identify bloodstream infection pathogens in as little as seven hours, versus two to seven days for conventional culturing. - The approach integrates single-cell imaging, computer algorithms, and antibiotic susceptibility testing to simultaneously name the pathogen and recommend effective antibiotics before sepsis develops. - Testing on about 100 positive blood samples showed comprehensive diagnosis within hours, though a 4% "very major error" rate and challenges with pre-treated patients remain hurdles before clinical use. - The framework offers a scalable foundation that could expand to fungal infections and aims to curb worsening antibiotic resistance through faster, more targeted treatment.